Search

Jerome Jackson Jr.

Examiner (ID: 15347, Phone: (571)272-1730 , Office: P/2815 )

Most Active Art Unit
2815
Art Unit(s)
2503, 2815, 2899, 2811
Total Applications
2143
Issued Applications
1551
Pending Applications
52
Abandoned Applications
543

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7210669 [patent_doc_number] => 20050053923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Detection of West Nile virus infection and vaccination' [patent_app_type] => utility [patent_app_number] => 10/937157 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8221 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053923.pdf [firstpage_image] =>[orig_patent_app_number] => 10937157 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/937157
Detection of West Nile virus infection and vaccination Sep 8, 2004 Issued
Array ( [id] => 5672459 [patent_doc_number] => 20060177813 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-10 [patent_title] => 'Novel high-throughput screening method of drug for bioactive protein' [patent_app_type] => utility [patent_app_number] => 10/571081 [patent_app_country] => US [patent_app_date] => 2004-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12099 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0177/20060177813.pdf [firstpage_image] =>[orig_patent_app_number] => 10571081 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/571081
High throughput screening method of drug for physiologically active protein Sep 7, 2004 Issued
Array ( [id] => 5820016 [patent_doc_number] => 20060024329 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Recombinant live vaccine based on canine herpesvirus, in particular against Carre\'s disease, rabies or the parainfluenza virus type 2.' [patent_app_type] => utility [patent_app_number] => 10/935494 [patent_app_country] => US [patent_app_date] => 2004-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 6455 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0024/20060024329.pdf [firstpage_image] =>[orig_patent_app_number] => 10935494 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/935494
Recombinant live vaccine based on canine herpesvirus, in particular against Carre's disease, rabies or the parainfluenza virus type 2. Sep 6, 2004 Abandoned
Array ( [id] => 5069542 [patent_doc_number] => 20070190644 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Treatment of spinal cord injury' [patent_app_type] => utility [patent_app_number] => 10/570402 [patent_app_country] => US [patent_app_date] => 2004-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 9780 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20070190644.pdf [firstpage_image] =>[orig_patent_app_number] => 10570402 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/570402
Treatment of spinal cord injury Sep 2, 2004 Issued
Array ( [id] => 876072 [patent_doc_number] => RE040233 [patent_country] => US [patent_kind] => E1 [patent_issue_date] => 2008-04-08 [patent_title] => 'Viral variants and methods for detecting same' [patent_app_type] => reissue [patent_app_number] => 10/920462 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7567 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/040/RE040233.pdf [firstpage_image] =>[orig_patent_app_number] => 10920462 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/920462
Viral variants and methods for detecting same Aug 17, 2004 Issued
Array ( [id] => 292072 [patent_doc_number] => 07544361 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-09 [patent_title] => 'Hetero type pentamer recombinant vaccine' [patent_app_type] => utility [patent_app_number] => 10/565595 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6494 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/544/07544361.pdf [firstpage_image] =>[orig_patent_app_number] => 10565595 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/565595
Hetero type pentamer recombinant vaccine Jul 22, 2004 Issued
Array ( [id] => 7208817 [patent_doc_number] => 20050053621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Safe mutant viral vaccines' [patent_app_type] => utility [patent_app_number] => 10/893712 [patent_app_country] => US [patent_app_date] => 2004-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8016 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20050053621.pdf [firstpage_image] =>[orig_patent_app_number] => 10893712 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/893712
Safe mutant viral vaccines Jul 15, 2004 Issued
Array ( [id] => 318509 [patent_doc_number] => 07521218 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-04-21 [patent_title] => 'Keratinocyte culturing method and the use thereof' [patent_app_type] => utility [patent_app_number] => 10/564964 [patent_app_country] => US [patent_app_date] => 2004-07-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 7922 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/521/07521218.pdf [firstpage_image] =>[orig_patent_app_number] => 10564964 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564964
Keratinocyte culturing method and the use thereof Jul 14, 2004 Issued
Array ( [id] => 7212330 [patent_doc_number] => 20050054107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Alpha virus-based cytomegalovirus vaccines' [patent_app_type] => utility [patent_app_number] => 10/886773 [patent_app_country] => US [patent_app_date] => 2004-07-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10438 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054107.pdf [firstpage_image] =>[orig_patent_app_number] => 10886773 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/886773
Alpha virus-based cytomegalovirus vaccines Jul 7, 2004 Issued
Array ( [id] => 330368 [patent_doc_number] => 07510863 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-03-31 [patent_title] => 'Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making' [patent_app_type] => utility [patent_app_number] => 10/868381 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 16128 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/510/07510863.pdf [firstpage_image] =>[orig_patent_app_number] => 10868381 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/868381
Avian pneumovirus genes, recombinant avian pneumoviruses and methods of making Jun 15, 2004 Issued
Array ( [id] => 7317492 [patent_doc_number] => 20040224310 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Anti-paratopic antibody as an immunogen' [patent_app_type] => new [patent_app_number] => 10/864526 [patent_app_country] => US [patent_app_date] => 2004-06-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 6984 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224310.pdf [firstpage_image] =>[orig_patent_app_number] => 10864526 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/864526
Anti-paratopic antibody as an immunogen Jun 9, 2004 Abandoned
Array ( [id] => 363339 [patent_doc_number] => 07482149 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-01-27 [patent_title] => 'Inhibition of SARS coronavirus infection with clinically approved antiviral drugs' [patent_app_type] => utility [patent_app_number] => 10/560198 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 6496 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/482/07482149.pdf [firstpage_image] =>[orig_patent_app_number] => 10560198 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/560198
Inhibition of SARS coronavirus infection with clinically approved antiviral drugs Jun 8, 2004 Issued
Array ( [id] => 7249410 [patent_doc_number] => 20040258665 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-23 [patent_title] => 'Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith' [patent_app_type] => new [patent_app_number] => 10/862036 [patent_app_country] => US [patent_app_date] => 2004-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8872 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20040258665.pdf [firstpage_image] =>[orig_patent_app_number] => 10862036 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/862036
Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith Jun 3, 2004 Issued
Array ( [id] => 295771 [patent_doc_number] => 07541038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-06-02 [patent_title] => 'Fusogenic, self-propagating blebs as immunogenic compositions' [patent_app_type] => utility [patent_app_number] => 10/559429 [patent_app_country] => US [patent_app_date] => 2004-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15140 [patent_no_of_claims] => 62 [patent_no_of_ind_claims] => 21 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/541/07541038.pdf [firstpage_image] =>[orig_patent_app_number] => 10559429 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/559429
Fusogenic, self-propagating blebs as immunogenic compositions Jun 1, 2004 Issued
Array ( [id] => 7083092 [patent_doc_number] => 20050048472 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Active truncated form of the RNA polymerase of flavivirus' [patent_app_type] => utility [patent_app_number] => 10/857244 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 5650 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048472.pdf [firstpage_image] =>[orig_patent_app_number] => 10857244 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857244
Active truncated form of the RNA polymerase of flavivirus May 27, 2004 Issued
Array ( [id] => 7295061 [patent_doc_number] => 20040213807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-10-28 [patent_title] => 'Use of Parapox B2L protein to modify immune responses to administered antigens' [patent_app_type] => new [patent_app_number] => 10/857546 [patent_app_country] => US [patent_app_date] => 2004-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4129 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20040213807.pdf [firstpage_image] =>[orig_patent_app_number] => 10857546 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857546
Use of Parapox B2L protein to modify immune responses to administered antigens May 27, 2004 Abandoned
Array ( [id] => 102297 [patent_doc_number] => 07723094 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-05-25 [patent_title] => 'Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy' [patent_app_type] => utility [patent_app_number] => 10/855975 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17992 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 323 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/723/07723094.pdf [firstpage_image] =>[orig_patent_app_number] => 10855975 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/855975
Recombinant influenza vectors with a polII promoter and ribozymes for vaccines and gene therapy May 26, 2004 Issued
Array ( [id] => 558690 [patent_doc_number] => 07470666 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-30 [patent_title] => 'Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome' [patent_app_type] => utility [patent_app_number] => 10/558226 [patent_app_country] => US [patent_app_date] => 2004-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1558 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/470/07470666.pdf [firstpage_image] =>[orig_patent_app_number] => 10558226 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/558226
Use of Ulinastatin and its pharmaceutical composition for treating severe acute respiratory syndrome May 24, 2004 Issued
Array ( [id] => 5642268 [patent_doc_number] => 20060280723 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Interferon for treating or preventing a coronaviral infection' [patent_app_type] => utility [patent_app_number] => 10/557761 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7199 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20060280723.pdf [firstpage_image] =>[orig_patent_app_number] => 10557761 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/557761
Interferon for treating or preventing a coronaviral infection May 18, 2004 Abandoned
Array ( [id] => 7061701 [patent_doc_number] => 20050004063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference' [patent_app_type] => utility [patent_app_number] => 10/848737 [patent_app_country] => US [patent_app_date] => 2004-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 20276 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0004/20050004063.pdf [firstpage_image] =>[orig_patent_app_number] => 10848737 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/848737
Inhibition of SARS-associated coronavirus (SCoV) infection and replication by RNA interference May 18, 2004 Issued
Menu